野生动物健康市场－全球产业规模、份额、趋势、机会和预测：按动物类型、产品、给药途径、最终用途、地区和竞争情况划分，2021-2031年

全球野生动物健康市场预计将从 2025 年的 134.6 亿美元大幅成长至 2031 年的 215.4 亿美元，复合年增长率为 8.15%。

此领域涵盖圈养和野生动物族群疾病管理所需关键工具的开发和应用，例如诊断方法、疫苗、药物和监测系统。市场成长趋势的强劲动力主要得益于全球范围内「同一健康」框架的实施，该框架将动物健康和人类健康相结合，并强调了保护生物多样性免受严重疾病爆发破坏性影响的严格保护义务。

儘管成长指标强劲，但该产业在监测和进入地理位置偏远地区的野生动物方面面临着巨大的后勤挑战，这常常导致漏报和对新兴病原体的反应迟缓。世界动物卫生组织（OIE）的数据显示，2025年1月至6月期间，58个国家和地区共报告了7062起野生动物疾病疫情和14757例指定病例，凸显了这项挑战。这些统计数据表明，在营运和地理环境复杂的情况下，维持有效的全球监测活动至关重要且难度高。

市场驱动因素

推动市场扩张的主要动力是感染疾病和新兴感染疾病的日益蔓延，这迫切需要诊断工具和监测通讯协定的快速发展。随着病原体跨越通用屏障传播，野生动物健康专家必须利用先进的监测系统，在病毒携带者影响人类健康或牲畜之前，识别出野生族群中的病毒携带者。欧洲食品安全局 (EFSA) 的一份报告强调了这一需求，该报告指出，仅在 2025 年 6 月至 9 月的三个月内，欧洲 15 个国家就检测到了 156 例高致病性禽流感病毒病例。感染率的广泛激增促使各国政府实施专门的兽医措施和防治方案，直接提升了市场收入。

此外，政府增加对保育计画的拨款和津贴，为高成本的野生动物健康干预措施提供了至关重要的资金来源。公共部门的投资对于鼓励治疗方法至关重要，而这些物种往往被私人投资者忽视。例如，美国农业部动植物卫生服务局于2025年6月向州和部落政府拨款1,200万美元，用于防治慢性消耗性疾病。明尼苏达大学报告称，到2025年，这种疾病已蔓延至36个州，因此，此类资金有助于应对日益严重的生态学威胁，而持续投入资金用于购置诊断设备和进行长期管理工作也至关重要。

市场挑战

全球野生动物健康市场面临巨大的成长障碍，这主要是由于在崎岖偏远地区进行野生动物监测工作存在许多后勤挑战。这些地理障碍造成了高成本的营运瓶颈，限制了必要的监测基础设施和诊断工具（例如野外检测套组和疫苗）的广泛部署。当兽医团队无法抵达极地地区、山区和茂密丛林中与世隔绝的动物种群时，数据收集就变成了间歇性的而非连续性的，这使得企业无法获得与长期疾病控制倡议相关的稳定收入来源。

这些物流限制的严重性体现在追踪广阔且难以到达地区快速传播的病原体的难度。例如，世界动物卫生组织（OIE）记录显示，2024年有55个国家和地区爆发了非家禽物种的高致病性禽流感疫情，显示监测方面有显着缺口。因此，物流摩擦导致可控疫情的发现延误，削弱了野生动物卫生措施的即时商业性应用和有效性，并阻碍了市场扩张。

市场趋势

先进的口服疫苗递送机制的研发正在改变疾病管理方式，无需个体捕捉即可在携带病毒的动物群体中实现群体免疫。这项创新技术显着降低了与传统捕捉和注射方法相关的安全风险和营运成本，使兽医团队能够控制生活在广阔且难以到达地区的野生食肉动物体内的病毒传播。透过空中和地面投放诱饵，卫生组织可以建立群体免疫缓衝区，防止病原体的扩散。 2025年8月，美国农业部在缅因州的一个计画制定了计划，拟投放约71.3万个口服狂犬病疫苗诱饵，以系统地控制当地野生动物体内的病毒传播。

同时，环境DNA（eDNA）作为一种非侵入性采样技术，正从根本上改变监测工作流程。它能够透过检测水、土壤和植物中存在的遗传痕迹来识别病原体和隐存物种。这项技术克服了物理采集和目视检查的局限性，为在传统监测难以进行的复杂生态系统中快速绘製宿主储存和生物多样性分布图提供了一种有效方法。这种分子生物学方法的高效性为解决后勤瓶颈问题提供了一个可扩展的方案。例如，根据美国国家野生动物联合会2024年9月发布的报告，研究人员利用eDNA技术在新泽西州的一片森林中，仅用一天时间就识别出了栖息在400英亩（约162公顷）森林中的约90%的哺乳动物物种。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球野生动物健康市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 动物种类（哺乳类、鸟类、鱼类、爬虫类、两栖类）
  • 依产品类别（药品、设备和耗材）
  • 给药途径（口服、注射、其他）
  • 依用途（动物园、野生动物保护区、野生动物救援中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美野生动物健康市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲野生动物健康市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区野生动物健康市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲野生动物健康市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲野生动物健康市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球野生动物健康市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Boehringer Ingelheim International GmbH
• NexGen Pharmaceuticals LLC
• Virbac SA
• Dong Bang Co., Ltd.
• Pneu-Dart Inc.
• DANiNJECT
• Genia Inc.
• Wedgewood Pharmacy LLC
• The Pet Apothecary
• Taylors Pharmacy LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Wildlife Health Market is projected to expand significantly, growing from USD 13.46 Billion in 2025 to USD 21.54 Billion by 2031, representing a Compound Annual Growth Rate (CAGR) of 8.15%. This sector comprises the development and deployment of essential tools such as diagnostics, vaccines, pharmaceuticals, and surveillance systems aimed at managing diseases in both captive and free-ranging wild animal populations. The market's upward trajectory is robustly underpinned by the global implementation of the One Health framework, which integrates animal and human well-being, alongside rigorous conservation mandates designed to shield biodiversity from the devastating impacts of severe disease outbreaks.

Despite these strong growth indicators, the industry faces a considerable obstacle regarding the logistical difficulties of monitoring and accessing wildlife in isolated geographic areas, which frequently leads to underreporting and delayed responses to emerging pathogens. Highlighting this challenge, data from the World Organisation for Animal Health indicates that between January and June 2025, 58 countries and territories reported 7,062 outbreaks and 14,757 cases of listed diseases in wildlife. These statistics emphasize the critical, yet arduous, nature of maintaining effective global surveillance efforts in the face of operational and geographical complexities.

Market Driver

A primary engine for market expansion is the escalating prevalence of zoonotic and emerging infectious diseases, which demands the rapid advancement of diagnostic utilities and surveillance protocols. As pathogens increasingly cross species barriers, wildlife health professionals must utilize sophisticated monitoring systems to identify viral reservoirs in free-ranging populations before they affect human health or livestock, a necessity underscored by the European Food Safety Authority's report of 156 highly pathogenic avian influenza virus detections across 15 European countries between June and September 2025 alone. This surge in widespread infection rates drives governments to acquire specialized veterinary countermeasures and containment solutions, directly boosting market revenue.

Furthermore, the increase in government funding and grants for conservation programs supplies the vital financial capital needed to support high-cost wildlife health interventions. Public sector investment is crucial for motivating institutions to create treatments for non-commercial species that are often overlooked by private investors, as evidenced by the USDA Animal and Plant Health Inspection Service's allocation of $12 million in June 2025 to state and tribal governments for controlling chronic wasting disease. With the University of Minnesota reporting the disease in 36 states in 2025, such funding addresses a growing ecological threat and necessitates sustained spending on diagnostic procurement and long-term management.

Market Challenge

The Global Wildlife Health Market encounters substantial growth barriers due to the logistical challenges inherent in accessing and monitoring wildlife within rugged and remote environments. These geographical obstacles create high-cost operational bottlenecks that restrict the widespread deployment of necessary surveillance infrastructures and diagnostics, such as field testing kits and vaccines. When veterinary teams are unable to physically reach isolated animal populations in polar regions, mountainous terrains, or dense forests, data collection becomes sporadic rather than continuous, preventing companies from securing consistent revenue streams tied to long-term disease management initiatives.

The severity of these logistical constraints is clearly demonstrated by the difficulty in tracking rapidly spreading pathogens across vast and inaccessible territories. For instance, the World Organisation for Animal Health recorded High Pathogenicity Avian Influenza outbreaks in non-poultry species across 55 countries and territories in 2024, illustrating the massive scale of the surveillance gap. Consequently, the market struggles to expand because logistical friction delays the detection of addressable outbreaks, thereby diminishing the immediate commercial application and effectiveness of wildlife health interventions.

Market Trends

The development of advanced oral vaccine delivery mechanisms is transforming disease management by facilitating the mass immunization of reservoir populations without requiring individual capture. This innovation significantly lowers the safety risks and operational costs associated with traditional trap-and-inject techniques, enabling veterinary teams to curb viral circulation in free-ranging carnivores across extensive, inaccessible areas. By employing aerial and ground-based bait distribution, health agencies can establish herd immunity buffers to prevent pathogen spillover, as demonstrated by the USDA's August 2025 project in Maine, which scheduled the distribution of approximately 713,000 oral rabies vaccine baits to systematically control the virus in local wildlife.

Concurrently, the application of environmental DNA (eDNA) for non-invasive sampling is fundamentally reshaping surveillance workflows by enabling the detection of disease vectors and cryptic species through genetic traces found in water, soil, or foliage. This technology circumvents the limitations of physical trapping and visual spotting, providing a rapid method to map host reservoirs and biodiversity in rugged ecosystems where traditional monitoring often falls short. The efficiency of this molecular approach offers a scalable solution to logistical bottlenecks; for example, a September 2024 report by the National Wildlife Federation noted that researchers using eDNA in a New Jersey forest successfully identified an estimated 90 percent of mammal species across 400 acres in just one day.

Key Market Players

• Boehringer Ingelheim International GmbH
• NexGen Pharmaceuticals LLC
• Virbac S.A.
• Dong Bang Co., Ltd.
• Pneu-Dart Inc.
• DANiNJECT
• Genia Inc.
• Wedgewood Pharmacy LLC
• The Pet Apothecary
• Taylors Pharmacy LLC

Report Scope

In this report, the Global Wildlife Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wildlife Health Market, By Animal Type

• Mammals
• Birds
• Fish
• Reptiles
• Amphibians

Wildlife Health Market, By Product

• Medicine
• Equipment & Consumables

Wildlife Health Market, By Route of Administration

• Oral
• Injectables
• Others

Wildlife Health Market, By End-Use

• Zoos
• Wildlife Sanctuaries
• Wildlife Rescue & Rehab Centers
• Others

Wildlife Health Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wildlife Health Market.

Available Customizations:

Global Wildlife Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wildlife Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Mammals, Birds, Fish, Reptiles, Amphibians)
  • 5.2.2. By Product (Medicine, Equipment & Consumables)
  • 5.2.3. By Route of Administration (Oral, Injectables, Others)
  • 5.2.4. By End-Use (Zoos, Wildlife Sanctuaries, Wildlife Rescue & Rehab Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Wildlife Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product
  • 6.2.3. By Route of Administration
  • 6.2.4. By End-Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Wildlife Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By End-Use
  • 6.3.2. Canada Wildlife Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By End-Use
  • 6.3.3. Mexico Wildlife Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By End-Use

7. Europe Wildlife Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product
  • 7.2.3. By Route of Administration
  • 7.2.4. By End-Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Wildlife Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By End-Use
  • 7.3.2. France Wildlife Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By End-Use
  • 7.3.3. United Kingdom Wildlife Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By End-Use
  • 7.3.4. Italy Wildlife Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Route of Administration
      • 7.3.4.2.4. By End-Use
  • 7.3.5. Spain Wildlife Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Route of Administration
      • 7.3.5.2.4. By End-Use

8. Asia Pacific Wildlife Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product
  • 8.2.3. By Route of Administration
  • 8.2.4. By End-Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Wildlife Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By End-Use
  • 8.3.2. India Wildlife Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By End-Use
  • 8.3.3. Japan Wildlife Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By End-Use
  • 8.3.4. South Korea Wildlife Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Route of Administration
      • 8.3.4.2.4. By End-Use
  • 8.3.5. Australia Wildlife Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Route of Administration
      • 8.3.5.2.4. By End-Use

9. Middle East & Africa Wildlife Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product
  • 9.2.3. By Route of Administration
  • 9.2.4. By End-Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Wildlife Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By End-Use
  • 9.3.2. UAE Wildlife Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By End-Use
  • 9.3.3. South Africa Wildlife Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By End-Use

10. South America Wildlife Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product
  • 10.2.3. By Route of Administration
  • 10.2.4. By End-Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Wildlife Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Route of Administration
      • 10.3.1.2.4. By End-Use
  • 10.3.2. Colombia Wildlife Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Route of Administration
      • 10.3.2.2.4. By End-Use
  • 10.3.3. Argentina Wildlife Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Route of Administration
      • 10.3.3.2.4. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Wildlife Health Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. NexGen Pharmaceuticals LLC
• 15.3. Virbac S.A.
• 15.4. Dong Bang Co., Ltd.
• 15.5. Pneu-Dart Inc.
• 15.6. DANiNJECT
• 15.7. Genia Inc.
• 15.8. Wedgewood Pharmacy LLC
• 15.9. The Pet Apothecary
• 15.10. Taylors Pharmacy LLC

16. Strategic Recommendations

17. About Us & Disclaimer